Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

10.88
Delayed Data
As of Jan 17
 -0.47 / -4.14%
Today’s Change
7.90
Today|||52-Week Range
14.15
+1.68%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close11.35
Today’s open11.29
Day’s range10.87 - 11.33
Volume989,332
Average volume (3 months)885,915
Market cap$1.2B
Dividend yield9.20%
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+427.50%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratio31.1
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...-0.66-2.15%
SUPNSupernus Pharmaceuti...-1.30-5.18%
SGYPSynergy Pharmaceutic...-0.25-3.71%
XNCRXencor Inc-2.85-10.89%
Data as of 01/17/2017

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$0.21
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs